glp-1 kidney cancer Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways From Diabetes to Oncology: Glucagon-like

Name: glp-1 kidney cancer Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways From Diabetes to Oncology: Glucagon-like
Brand: matisco.be
SKU: 36765644475
Price: 28.47 USD
Availability: InStock
Rating: 4.3870000000000005 (19 reviews)

SKU: 36765644475

4.4

USD28.47 USD57.47

Pay in 4 interest-free payments of $7.12 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

From Diabetes to Oncology: Glucagon like Peptide 1 (GLP 1) Receptor Agonist's Dual Role in Prostate Cancer Kidney cancer trend and GLP 1s: a promising dataset Ken Grossmann posted on the topic LinkedIn Most studies of GLP 1 agonists have not identified an increased overall risk of cancer. However, two large real world studies have reported an elevated risk of kidney cancer. Dai et al. (JAMA New Molecules and Emerging Indications for GLP 1 Medicines Color coding Download Scientific Diagram

Store: matisco.be · Domain: matisco.be

Description